The Russell 2000 Index has soared, but you -2-
Omega Therapeutics Inc. OMGA 100% $3.01 $12.00 299% Allogene Therapeutics Inc. ALLO 82% $3.21 $12.79 298% X4 Pharmaceuticals Inc. XFOR 86% $0.84 $3.26 289% Caribou Biosciences Inc. CRBU 89% $5.73 $22.25 288% Stoke Therapeutics Inc. STOK 78% $5.26 $19.33 268% Source: FactSet
That's right - this Russell 2000 list is all biotech. And in case you are wondering if any companies are on both lists, the answer is no.
Don't miss: 11 dividend stocks with high yields expected to be well supported in 2024 per strict criteria
-Philip van Doorn
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
01-06-24 0558ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
Alibaba Earnings: More Positive Outlook Despite Mixed Results
-
After Earnings and a 56% Rally In 2024, Is Arm Stock a Buy, a Sell, or Fairly Valued?
-
How Morningstar Rates Stocks
-
After Earnings, Is Disney Stock a Buy, a Sell, or Fairly Valued?
-
Home Depot Earnings: Macro Factors Pinch Demand, but Long-Term Outlook Intact
-
Tariffs On Chinese EVs Offer US Automakers a Chance to Capture Demand
-
The Best REITs to Buy
-
3 Hot Stocks to Buy That Still Look Undervalued